Drugs of Abuse (DOA)

From routine screening to specialized testing for emerging drugs, our Drugs of Abuse portfolio provides a broad, reliable menu designed for use on your existing clinical chemistry analyzers.

CEDIA® & DRI™ Drugs of Abuse Immunoassays

Thermo Fisher Scientific

One of the most extensive drugs of abuse immunoassay menus in the industry, combining two proven technology platforms CEDIA and DRI. Both offer qualitative or semi-quantitative results with validated applications across a wide range of clinical chemistry analyzers, including the Indiko series.

Our test portfolio includes:

  • Amphetamine
  • Ecstasy
  • Cocaine
  • THC (cannabinoids)
  • Barbiturate
  • Benzodiazepine
  • Methaqualone
  • Phencyclidine
  • Opiate
  • Heroin metabolite
  • Methadone
  • Methadone metabolite
  • Oxycodone
  • Hydrocodone
  • Propoxyphene
  • Buprenorphine II
  • Ethyl alcohol
  • Ethyl glucuronide
  • Cotinine
  • Fentanyl
  • LSD

A full range of calibrators and multi-constituent control sets is available to support each assay.

Want to learn more about our various products?

Kindly send us an enquiry.

Get in Touch